Oilseed medicinals: In natural drugs, dietary supplements and in new functional foods

Trends in Food Science and Technology

Volumn 13, Issue 11, 2002, Pages 353-360

  Reichert, Robert D ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; HEALTH CARE; HEALTH INSURANCE; MARKETING; NUTRITION;

THERAPEUTIC USES;

OILS AND FATS;

EID: 0036881221     PISSN: 09242244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-2244(02)00183-8     Document Type: Article

References (62)

1. Agricultural Research Service (1999). USDA's 1994-96 continuing survey of food intakes by individuals. Beltsville, MD, US Dept. of Agriculture.
2. Berges R.R., Kassen A., Senge T. Treatment of symptomatic benign prostatic hyperplasia with β-sitosterol. an 18-month follow-up British Journal of Urology. 85:2000;842-846.
3. Beyer, P. & Potrykus, I. (2000) Method for improving the agronomic and nutritional value of plants. Greenovation Pflanzenbiotechnologie GMBH, Freiburg, Germany, 48p, WO patent 00/53768.
4. Blackburn G.L. Pasteur's quadrant and malnutrition. Nature. 409:2001;397-401.
5. Borowy-Borowski, H., Sikorska-Walker, M. & Walker, P. R. (2000), Water-soluble compositions of bioactive lipophilic compounds. National Research Council of Canada, Ottawa, Canada, 19p, USA patent 6,045,826.
6. Bouic P.J.D., Etsebeth S., Liebenberg R.W., Albrecht C.F., Pegel K., van Jaarsveld P.P. Beta-sitosterol and beta-sitosterol glucoside stimulate human peripheral blood lymphocyte proliferation. implications for their use as an immunomodulatory vitamin combination International Journal of Immunopharmacy. 18:1996;693-700.
7. Brower, V. (1998). Nutraceuticals: poised for a healthy slice of the healthcare market? Nature Biotechnology, 16, 728-731.
8. Bryhn, M. Personal communication, Pronova Biocare, Norway.
9. Burke C. Oily success. Functional Foods and Nutraceuticals. 3:2000;32.
10. Economic Research Service Food consumption, prices and expenditures. 2001;US Dept of Agriculture, Washington DC.
11. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association. 285:2001;2486-2497.
12. Facciotti, D., Metz, J.G. & Lassner, M. (2000). Production of polyunsaturated fatty acids by expression of polyketide-like synthesis genes in plants. Calgene Inc., California, USA, 124p, USA Patent 6,140,486.
13. 12 , pantothenic acid, biotin, and choline. 1998;National Academy of Sciences, National Academy Press, Washington, DC.
14. Dietary reference intakes for vitamin C, vitamin E, selenium and carotenoids. 2000;National Academy of Sciences, National Academy Press, Washington DC.
15. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. 2001;National Academy of Sciences, National Academy Press, Washington DC.
16. Gateley C.A., Miers M., Mansel R.E., Hughes L.E. Drug treatments for mastalgia. 17 years experience in the Cardiff Mastalgia Clinic Journal of the Royal Society of Medicine. 85:1992;12-15.
17. Grant M. Dieting for an Emperor. Scarborough J. Studies in ancient medicine (vol. 15). 1997;E.J. Brill Co, New York, NY.
18. Grubert N. The impact of Rx-to-OTC switching on the pharmaceutical market. 2001;Decision Resources Inc, Waltham, Mass.
19. Hollingsworth P., Hicks K.B., Moreau R.A. Development of cholesterol-fighting foods. Food Technology. 55:2001;59-67.
20. Imai, Y., Tomonari, O., Chiho, T., Masatoshi, K. & Hidero, T. (1996), Food additive and use thereof. Amano Pharmaceutical Co. Ltd., Nagoya, Japan, 31p. USA patent 5,514,398.
21. Jailwala J., Imperiale T.F., Kroenke K. Pharmacologic treatment of the irritable bowel syndrome. a systematic review of randomized, controlled trials Annals of International Medicine. 133:2000;136-147.
22. Japanese Ministry of Health and Welfare. (June 2000). Foods for specified health uses (FOSHU). Tokyo.
23. Kamei M., Fujita T., Kanbe T., Sasaki K., Oshiba K., Otami S., Matsui-Yuasa I., Morisawa S. The distribution and content of ubiquinone in foods. International Journal of Vitamin and Nutrition Research. 56:1986;57-63.
24. Karunanandaa, B., Jaehyuk, Y. & Kishore, G. M. (2001). Nucleic acid molecules and other molecules associated with sterol synthesis and metabolism. Pharmacia Corp., USA, 96p, WO patent 00104314A2.
25. Kishore G.M., Shewmaker C.K. Biotechnology. enhancing human nutrition in developing and developed worlds Proceedings of the National Academy of Sciences. 96:1999;5968-5972.
26. Kushima K., Hasegawa N., Nakano S. Drug efficacy evaluation of gamma-oryzanol for menopausal disorders by double-blind test. Gynecological Practice. 25:1976;1099-1111. (in Japanese).
27. Law M. Plant sterol and stanol margarines and health. British Medical Journal. 320:2000;861-864.
28. Leung D.Y.M., Soter N.A. Cellular and immunologic mechanisms in atopic dermatitis. Journal of the American Academy of Dermatology. 44:2001;S1-S12.
29. Liu J.W., DeMichele S., Bergana M., Bobik E., Hastilow C., Chuang L.T., Mukerji P., Huang Y.S. Characterization of oil exhibiting high γ-linolenic acid from a genetically transformed canola strain. Journal of the American Oil Chemists' Society. 78:2001;489-493.
30. Miettenen, T., Wester, I., & Vanhanen, H. (2001). Substance for lowering high cholesterol level in serum and methods for preparing and using the same. Raisio Benecol, Ltd., Raisio, Finland, 12p, USA patent 6,174,560.
31. Morse P.F., Horrobin D.F., Manku M.S., Stewart J.C.M., Allen R., Littlewood S., Wright S., Burton J., Gould D.J., Holt P.J., Jansen C.T., Mattila L., Meigel W., Dettke Th., Wexler D., Guenther L., Bordoni A., Patirizi A. Meta-analysis of placebo-controlled studies of the efficacy of epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response. British Journal of Dermatology. 121:1989;75-90.
32. Namiki M.et al. Clinical evaluation of gamma-oryzanol against gastrointestinal psychosomatic disorders; double blind comparative test. Rinsyo to Kenkyu (Clinic and Research). 59:1982;955-963. (Japanese).
33. Niederau C., Strohmeyer G., Heinteges T., Peter K., Gopfert E. Polyunsaturated phosphatidylcholine and interferon alpha for treatment of chronic hepatitis B and C. a multi-center, randomized, double-blind, placebo-controlled trial Hepato-Gastroenterology. 45:1998;797-804.
34. Nunn J.F. Ancient egyptian medicine. 1996;U. of Oklahoma/British Museum Press, London, UK.
35. Orimo H., Fujita T., Onomura T., Inoue T., Kushida K., Shiraki M. Clinical evaluation of Ea-0167 (menatrenone) in the treatment of osteoporosis. Clinical Evaluation (Tokyo). 20:1992;45-100. (in Japanese).
36. 10 in health and disease. European Journal of Clinical Nutrition. 53:1999;764-770.
37. Panos M.Z., Polson R., Johnson R., Portmann B., Williams R. Polyunsaturated phosphatidylcholine for acute alcoholic hepatitis. a double blind, randomized, placebo-controlled trial European Journal of Gastroenterology and Hepatology. 2:1990;351-355.
38. Pepeu C., Pepeu I.M., Amaducci L. A review of phosphatidylserine pharmacological and clinical effects. Is phosphatidylserine a drug for the aging brain? Pharmacological Research. 33:1996;73-80.
39. Put A., Samochowiec L., Ceglecka M., Tustanowski S., Birkenfeld B., Zaborek B. Clinical efficacy of "essential" phospholipids in patients chronically exposed to organic solvents. Journal of International Medical Research. 21:1993;185-191.
40. Pye J.K., Mansel R.E., Hughes L.E. Clinical experience of drug treatments for mastalgia. Lancet 17 August. 1985;373-377.
41. Ramamurthi S., McCurdy A.R., Tyler R.T. Deodorizer distillate: a valuable by-product. Koseoglu S.S., Rhee K.C., Wilson R.F. Emerging technologies, current practices, quality control, technology transfer, and environmental issues. 1998;130-134 AOCS Press, Champaign, IL.
42. Reddy A.S., Thomas T.L. Expression of a cyanobacterial Δ6-desaturase gene results in γ-linolenic acid production in transgenic plants. Nature Biotechnology. 14:1996;639-642.
43. Scherz H., Senser F. Food composition and nutrition tables. 6th ed. 2000;Medpharm GmbH Scientific Publishers, Stuttgart, Germany.
44. Sherer M.J. Vitamin K. Lancet. 345:1995;229-234.
45. Shewmaker, C. K. (1998). Methods for producing carotenoid compounds and specialty oils in plant seeds. Calgene Inc., California, USA, 68p. WO patent 98/06862.
46. Shiller L.R. The therapy of constipation. Alimentary Pharmacology & Therapeutics. 15:2001;749-763.
47. Shintani D., DellaPenna D. Elevating the vitamin E content of plants through metabolic engineering. Science. 282:1998;2098-2100.
48. Shintani, D. and DellaPenna, D. (2000). Manipulation of tocopherol levels in transgenic plants. University of Nevada, USA, 36p, PCT patent US99/19483.
49. Smith M., Moon H., Kunst L. Production of hydroxy fatty acids in the seeds of Arabidopsis thaliana. Biochemical Society Transactions. 28:2000;947-950.
50. Sokol R.J., Heubi J.E., Butler-Simon N., McClung H.J., Lilly J.R., Silverman A. Treatment of vitamin E deficiency during chronic childhood cholestasis with oral d-α-tocopheryl polyethylene glycol-1000 succinate. Gastroenterology. 93:1987;975-985.
51. Somerville, C. and van de Loo, F. (2000). Plant fatty acid hydroxylase. Carnegie Institution, Washington, DC, 65p, USA patent 6,028,248.
52. South-Paul J.E. Osteoporosis. part I, evaluation and assessment American Family Physician. 63:2001;867-904, 908.
53. The National Prescribing Centre Atopic eczema and mastalgia. the place of evening primrose oil MeReC Bulletin. 9:1998;5-8.
54. Thomas, T. L., Reddy, A. S., Nuccio, M., & Freyssinet, G.L. (1997). Production of gamma linolenic acid by a Δ6-desaturase. Texas A & M University, USA, 16p, USA Patent 5,689,050.
55. Todd D.J. Erythropoietic protoporphyria. British Journal of Dermatology. 131:1994;751-766.
56. Traber M.G., Schiano T.D., Steephen A.C., Kayden H.J., Shike M. Efficacy of water-soluble vitamin E in the treatment of vitamin E malabsorption in short-bowel syndrome. American Journal of Clinical Nutrition. 59:1994;1270-1274.
57. Interim final ruling on food labelling. health claims; plant sterol/stanol esters and coronary heart disease FDA Federal Register. 65:2000;54685-54739.
58. Venkatramesh, M., Corbin, D. R., Bhat, G. B, Boddupalli, S. S., Grebenok, R. J., Kishore, G. M., Lardizabal, K. D., Rangwala, S. H., & Karunanandaa, B (2000). Transgenic plants containing altered levels of sterol compounds and tocopherols. Monsanto CO, USA, 167p, WO patent 00061771A2.
59. Walsh L., Winters R.L., Gonzalez R.G. Optimizing deodorizer distillate tocopherol yields. INFORM. 9:1998;78-83.
60. Work Group on Alzheimer's Disease Related Dementias. Practice guidelines for the treatment of patients with Alzheimer's disease and other dementias of late life. American Psychiatric Association Practice Guidelines, 39p supplement. American Journal of Psychiatry. 154:1997;5.
61. Ye X., Al-Babili S., Klöti A., Zhang J., Lucca P., Beyer P., Potrykus I. Engineering the provitamin A (β-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm. Science. 287:2000;303-305.
62. Yoshino G., Kazumi T., Amono M., Tateiwa M., Yamasaki T., Takashima S., Iwai M., Hatankana H., Baba S. Effects of gamma-oryzanol on hyperlipidemic subjects. Current Therapeutic Research. 45:1989;543-552.